S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Abbott Laboratories Outlook is Healthy: Buy the Dip
Closing prices for crude oil, gold and other commodities
Stock market today: World shares are mixed after a tech-led retreat on Wall Street
Prologis Stock Leading U.S. Logistics Boom
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Abbott Laboratories Outlook is Healthy: Buy the Dip
Closing prices for crude oil, gold and other commodities
Stock market today: World shares are mixed after a tech-led retreat on Wall Street
Prologis Stock Leading U.S. Logistics Boom
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Abbott Laboratories Outlook is Healthy: Buy the Dip
Closing prices for crude oil, gold and other commodities
Stock market today: World shares are mixed after a tech-led retreat on Wall Street
Prologis Stock Leading U.S. Logistics Boom
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Abbott Laboratories Outlook is Healthy: Buy the Dip
Closing prices for crude oil, gold and other commodities
Stock market today: World shares are mixed after a tech-led retreat on Wall Street
Prologis Stock Leading U.S. Logistics Boom

MedEquities Realty Trust (MRT) Competitors

Notice: This company has been marked as potentially delisted and may not be actively trading.

MRT vs. GETR, RCAT, AQMS, MAQC, UCL, HAO, SSNT, ECX, MFH, and CNGL

Should you be buying MedEquities Realty Trust stock or one of its competitors? The main competitors of MedEquities Realty Trust include Getaround (GETR), Red Cat (RCAT), Aqua Metals (AQMS), Maquia Capital Acquisition (MAQC), uCloudlink Group (UCL), Haoxi Health Technology (HAO), SilverSun Technologies (SSNT), ECARX (ECX), Mercurity Fintech (MFH), and Canna-Global Acquisition (CNGL). These companies are all part of the "business services" sector.

MedEquities Realty Trust vs.

Getaround (NYSE:GETR) and MedEquities Realty Trust (NYSE:MRT) are both small-cap business services companies, but which is the better stock? We will compare the two companies based on the strength of their analyst recommendations, profitability, media sentiment, institutional ownership, community ranking, risk, valuation, earnings and dividends.

MedEquities Realty Trust has a net margin of 0.00% compared to MedEquities Realty Trust's net margin of -156.78%. Getaround's return on equity of 0.00% beat MedEquities Realty Trust's return on equity.

Company Net Margins Return on Equity Return on Assets
Getaround-156.78% -496.56% -66.37%
MedEquities Realty Trust N/A N/A N/A

MedEquities Realty Trust has lower revenue, but higher earnings than Getaround.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Getaround$72.68M0.30-$113.95M-$1.23-0.19
MedEquities Realty Trust$24.99M2.82-$14.25MN/AN/A

MedEquities Realty Trust has a consensus target price of $0.90, suggesting a potential downside of 37.93%. Given Getaround's higher possible upside, analysts plainly believe MedEquities Realty Trust is more favorable than Getaround.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Getaround
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A
MedEquities Realty Trust
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00

59.6% of Getaround shares are owned by institutional investors. Comparatively, 20.7% of MedEquities Realty Trust shares are owned by institutional investors. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

MedEquities Realty Trust received 222 more outperform votes than Getaround when rated by MarketBeat users. However, 100.00% of users gave Getaround an outperform vote while only 64.10% of users gave MedEquities Realty Trust an outperform vote.

CompanyUnderperformOutperform
GetaroundOutperform Votes
3
100.00%
Underperform Votes
No Votes
MedEquities Realty TrustOutperform Votes
225
64.10%
Underperform Votes
126
35.90%

In the previous week, MedEquities Realty Trust had 3 more articles in the media than Getaround. MarketBeat recorded 3 mentions for MedEquities Realty Trust and 0 mentions for Getaround. MedEquities Realty Trust's average media sentiment score of 0.84 beat Getaround's score of 0.00 indicating that Getaround is being referred to more favorably in the media.

Company Overall Sentiment
Getaround Positive
MedEquities Realty Trust Neutral

Summary

MedEquities Realty Trust beats Getaround on 9 of the 13 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding MRT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

MRT vs. The Competition

MetricMedEquities Realty TrustAutomotive rental & leasing, without drivers IndustryBusiness SectorNYSE Exchange
Market Cap$70.44M$2.99B$6.37B$17.17B
Dividend YieldN/A2.49%3.11%3.60%
P/E RatioN/A9.3834.7823.48
Price / Sales2.820.651,050.2710.07
Price / CashN/A4.4223.2716.85
Price / BookN/A3.174.514.85
Net Income-$14.25M$435.86M$122.87M$965.88M

MedEquities Realty Trust Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
GETR
Getaround
0 of 5 stars
$0.26
flat
N/A-10.6%$24.32M$72.68M-0.21290Gap Up
RCAT
Red Cat
0 of 5 stars
$0.84
+2.5%
N/A+52.7%$62.10M$9.91M-1.6176Gap Up
AQMS
Aqua Metals
1.8505 of 5 stars
$0.60
-3.2%
$3.00
+403.9%
-57.4%$66.66M$30,000.00-2.2930Short Interest ↓
Positive News
Gap Down
MAQC
Maquia Capital Acquisition
0 of 5 stars
$10.98
flat
N/AN/A$67.86MN/A0.004Positive News
UCL
uCloudlink Group
3.1292 of 5 stars
$1.60
+2.6%
N/A-61.4%$59.92M$85.58M20.00330Gap Down
HAO
Haoxi Health Technology
0 of 5 stars
$4.72
+8.3%
N/AN/A$68.96M$28.23M0.0032Gap Down
SSNT
SilverSun Technologies
0 of 5 stars
$12.98
+3.4%
N/A+382.7%$69.05M$54.52M-64.90195Gap Up
ECX
ECARX
0.8759 of 5 stars
$1.87
-4.1%
$10.00
+434.8%
-69.3%$70.13M$4.67B-4.921,501News Coverage
MFH
Mercurity Fintech
0 of 5 stars
$1.21
+8.0%
N/A+12.6%$56.25M$860,000.000.009Upcoming Earnings
News Coverage
Gap Up
CNGL
Canna-Global Acquisition
0 of 5 stars
$11.02
flat
N/A+2.0%$72.84MN/A0.00N/A

Related Companies and Tools

This page (NYSE:MRT) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners